Revolutions Medical Corporation Awarded Judgment Against Globe Medical Tech, Inc.

        Print
| Source: Revolutions Medical Corporation

CHARLESTON, S.C., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (OTCQB:RMCP) ("Revolutions Medical" or the "Company") was granted its request for summary judgment against Globe Medical Tech, Inc. ("Globe Medical") and awarded $311,440 and the return of 266,667 shares of the Company's common stock by a Federal District Court in Tulsa County, Oklahoma.

In addition to the monetary award and the return of the Company's common stock, Globe Medical is also required to return all syringes, design files, and sample molds to the Company. Furthermore, the Court ordered that Globe Medical assign to the Company all rights to the January 2009 issued United States patent for the RevVac™ auto-retractable safety syringe. Globe Medical is prohibited from claiming any interest or ownership in Revolutions Medical's safety vacuum syringes going forward.

"The award is a substantial victory for the Company and our shareholders," stated Ron Wheet, Chief Executive Officer of Revolutions Medical. "This final judgment clears the path for future strategic relationships involving potential distribution and licensing of the RevVac™ auto-retractable vacuum safety syringe."

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ Safety Syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™ and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).

For additional information, please visit Revolutions Medical corporate website:

www.revolutionsmedical.com

To be added to the Revolutions Medical investor email list, please email:

investment@revolutionsmedical.com with RMCP in the subject line.

Forward Looking Statements

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Revolutions Medical Corporation
Investor and Corporate Relations
Gregory S. Lowe
Acorn Management Partners
President / Partner
678-368-4013